Evidence map›Paper›PMID 34633135›Full record

ArticleChembiochem : a European journal of chemical biology2022

Controlling Enzymatic Activity by Modulating the Oligomerization State via Chemical Rescue and Optical Control.

Cosimo Kropp, Astrid Bruckmann, Patrick Babinger

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Biochemical and functional characterization ofFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cosimo KroppInstitute of Biophysics and Physical Biochemistry, Regensburg Center for Biochemistry, University of Regensburg, 93040, Regensburg, Germany.ORCID 0000-0002-7875-3323
Astrid BruckmannInstitute of Biochemistry, Genetics and Microbiology, Regensburg Center for Biochemistry, University of Regensburg, 93040, Regensburg, Germany.
Patrick BabingerInstitute of Biophysics and Physical Biochemistry, Regensburg Center for Biochemistry, University of Regensburg, 93040, Regensburg, Germany.ORCID 0000-0002-7490-6732

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective switching of enzymatic activity has been a longstanding goal in synthetic biology. Drastic changes in activity upon mutational manipulation of the oligomerization state of enzymes have frequently been reported in the literature, but scarcely exploited for switching. Using geranylgeranylglyceryl phosphate synthase as a model, we demonstrate that catalytic activity can be efficiently controlled by exogenous modulation of the association state. We introduced a lysine-to-cysteine mutation, leading to the breakdown of the active hexamer into dimers with impaired catalytic efficiency. Addition of bromoethylamine chemically rescued the enzyme by restoring hexamerization and activity. As an alternative method, we incorporated the photosensitive unnatural amino acid o-nitrobenzyl-O-tyrosine (ONBY) into the hexamerization interface. This again led to inactive dimers, but the hexameric state and activity could be recovered by UV-light induced cleavage of ONBY. For both approaches, we obtained switching factors greater than 350-fold, which compares favorably with previously reported activity changes that were caused by site-directed mutagenesis.

Indexed as

TyrosineCatalysisMutagenesis, Site-DirectedTyrosinebiocatalysischemical rescueoligomerizationoptochemical toolsprotein-protein interactions

Identifiers

PMID34633135
PMCPMC9298306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.